Drug Trial Radar · NCT01984684
Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Last checked: Nov 20, 2026Latest source record: Nov 17, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
850
Actual
Start
May 2014
Primary completion
Dec 2015
Study completion Jan 2016
Sponsor
- Lead sponsor
- Melinta Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 15, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effects of Delafloxacin versus Vancomycin plus Aztreonam in the treatment of patients with acute bacterial skin and soft tissue infections.
Conditions
- Skin and Subcutaneous Tissue Bacterial Infections
- Skin Structures and Soft Tissue Infections
Interventions
delafloxacinDrug
vancomycinDrug
aztreonamDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response of ≥20% Reduction in Lesion Erythema Area Compared to Baseline at 48 to 72 Hours After Initiation of Treatment as Determined by Digital Measurements of the Leading Edge.Time frame: 48 to 72 hrs after starting treatment
Locations
94 sites in 16 countries. Site status is shown where the registry gives one.
Melinta 303 Study Site
Mobile, Alabama
Melinta 303 Study Site
Montgomery, Alabama
Melinta 303 Study Site
Anaheim, California
Melinta 303 Study Site
Chula Vista, California
Melinta 303 Study Site
La Mesa, California
Melinta 303 Study Site
Long Beach, California
Melinta 303 Study Site
Modesto, California
Melinta 303 Study Site
Oceanside, California
Melinta 303 Study Site
San Diego, California
Melinta 303 Study Site
Stockton, California
Melinta 303 Study Site
Torrance, California
Melinta 303 Study Site
DeLand, Florida
Melinta 303 Study Site
Orlando, Florida
Melinta 303 Study Site
Columbus, Georgia
Melinta 303 Study Site
Savannah, Georgia
Melinta 303 Study Site
Eunice, Louisiana
Melinta 303 Study Site
Springfield, Massachusetts
Melinta 303 Study Site
Minneapolis, Minnesota
Melinta 303 Study Site
Butte, Montana
Melinta 303 Study Site
Lincoln, Nebraska
Melinta 303 Study Site
Las Vegas, Nevada
Melinta 303 Study Site
Somers Point, New Jersey
Melinta 303 Study Site
Teaneck, New Jersey
Melinta 303 Study Site
Columbus, Ohio
Melinta 303 Study Site
Toledo, Ohio
Melinta 303 Study Site
Rapid City, South Dakota
Melinta 303 Study Site
Jackson, Tennessee
Melinta 303 Study Site
Smyrna, Tennessee
Melinta 303 Study Site
Channelview, Texas
Melinta 303 Study Site
Houston, Texas
Melinta 303 Study Site
San Antonio, Texas
Melinta 303 Study Site
Córdoba, Argentina
Melinta 303 Study Site
Santa Fe, Argentina
Melinta 303 Study Site
La Plata, Buenos Aires, Argentina
Melinta 303 Study Site
Rosario, Santa Fe Province, Argentina
Melinta 303 Study Site
São Paulo, Brazil
Melinta 303 Study Site
Salvador, Estado de Bahia, Brazil
Melinta 303 Study Site
Belo Horizonte, Minas Gerais, Brazil
Melinta 303 Study Site
Lavras, Minas Gerais, Brazil
Melinta 303 Study Site
Passo Fundo, Rio Grande do Sul, Brazil
Showing 40 of 94 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.